Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of oral Calcium Dobesilate to oral
Cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women
underwent intracytoplasmic sperm injection (ICSI).